Press release
Registration is now open for Oligonucleotide Therapeutics and Delivery Conference
SAE Media Group reports: The 2nd Annual Oligonucleotide Therapeutics & Delivery Conference is set to return in September 2022 with a key focus on advancements in extra-hepatic delivery of oligonucleotides.SAE Media Group is delighted to announce the 2nd Annual Conference Oligonucleotide Therapeutics & Delivery, taking place on the 21st and 22nd September 2022 in London, UK. The 2022 Conference theme is on the latest advances in oligonucleotide discovery and delivery.
Chairs for the conference are industry expert Ekkehard Leberer, Senior Consultant, Elbiocon, and Jim Weterings, Principal Scientist, AstraZeneca.
Also taking place is the Oligonucleotide Therapeutics & Delivery two interactive Workshops on the 20th September 2022.
Interested parties can register for the conference and workshop at:
http://www.oligonucleotide.co.uk/PR1openPR and take advantage of the early bird offer to save £300 which expires 31st May 2022.
By attending the conference attendees will have the opportunity to
•Listen to case studies presenting on pre-clinical and clinical research in areas such as oncology and what can be learned for future clinical trials
•Deepen your understanding of oligonucleotide therapeutic delivery and explore the latest innovations in extrahepatic oligonucleotide delivery and target specificity
•Understand the regulatory and CMC environment surrounding oligonucleotide therapeutic development
•Explore developments in oligonucleotide chemistries and examine developments in novel applications of antisense oligonucleotides and siRNA
•Engage in the latest innovations in oligonucleotide therapeutics such as utilising AI machine learning to drive the discovery of novel therapeutics
Building on the success of previous years of the RNA Portfolio, the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference will bring together industry experts from big pharma and leading biotechs to gain an expert and holistic view on the latest developments of the industry.
View the agenda and speaker line - up at http://www.oligonucleotide.co.uk/PR1openPR
For sponsorship enquiries contact Luke Teachen on +44 (0) 20 7827 6002 or email: lteachen@smi-online.co.uk
For media enquiries or a press pass contact Marketing, Nikisha Galoria on +44 (0) 20 7827 6154 or email ngaloria@smi-online.co.uk
Oligonucleotide Therapeutics & Delivery Conference
21-22 September 2022
London, UK
#OligoTx
http://www.oligonucleotide.co.uk/PR1openPR
--- ENDS ---
India House, 45 Curlew Street
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Registration is now open for Oligonucleotide Therapeutics and Delivery Conference here
News-ID: 2620684 • Views: …
More Releases from SAE Media Group

Launch of the C-UAS Hub Report 2025: Countering the Threat: A Comprehensive Revi …
SAE Media Group, renowned for its sell-out Counter UAS Conferences and owner of the C-UAS Hub, is excited to announce the release of its first-ever C-UAS Hub Report 2025, titled "Countering the Threat: A Comprehensive Review of National C-UAS Programs."
As drones continue to play an increasingly prominent role in both military and civilian sectors, the demand for effective Counter UAS solutions is growing rapidly. NATO allies are making significant investments…

How MilSatCom has transformed warfare and continues to shape the battlefield.
The advancement of space-based communications technologies, including the ever-increasing presence of military satellites for electronic and signals intelligence purposes, has dramatically changed the way wars are fought down on Earth.
From the launch of the first satellite communications network to the cutting-edge technology that is still in development, below we take a look at how far MilSatCom has come.
A brief history of MilSatCom
The first military communications satellites were launched by the…

Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
The 2023 Conference theme is on exploring the implementation of complex in-vitro models for drug development
Visit the website at http://www.3d-cellculture.com/PR2 to find out…

Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to…
More Releases for Oligonucleotide
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period…
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from…
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease…
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User
(Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According…
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis…
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Agilent Technologies
Biosearch Technologies
Eurofins Genomics
Eurogentec
Integrated DNA Technologies
Merck KGAA
Thermo Fisher Scientific
GeneDesign
Bio-Synthesis - CRO/CMO Life Sciences Company
Bioautomation
GE Healthcare
LGC Biosearch Technologies
NITTO Denko Avecia
For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022
Market segment by Regions/Countries, this report…